These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 7001614)
1. Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass. Lauritsen KB; Christensen KC; Stokholm KH Scand J Gastroenterol; 1980; 15(4):489-95. PubMed ID: 7001614 [TBL] [Abstract][Full Text] [Related]
2. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man. Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526 [TBL] [Abstract][Full Text] [Related]
3. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease. Lauritsen KB; Lauritzen JB; Christensen KC Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103 [TBL] [Abstract][Full Text] [Related]
4. The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP). Jorde R; Burhol PG; Johnson JA Scand J Gastroenterol; 1981; 16(2):313-9. PubMed ID: 7031848 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity. Heptulla RA; Tamborlane WV; Cavaghan M; Bronson M; Limb C; Ma YZ; Sherwin RS; Caprio S Pediatr Res; 2000 May; 47(5):628-33. PubMed ID: 10813588 [TBL] [Abstract][Full Text] [Related]
6. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Ebert R; Illmer K; Creutzfeldt W Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554 [TBL] [Abstract][Full Text] [Related]
7. Release of gastric inhibitory polypeptide (GIP) and gastrin after a test meal with a low glucose load in patients after BII resection, proximal duodenopancreatectomy (PDP) and jejunoileal bypass. Klapdor R Res Exp Med (Berl); 1982; 181(1):11-8. PubMed ID: 7134635 [TBL] [Abstract][Full Text] [Related]
8. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat. Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459 [TBL] [Abstract][Full Text] [Related]
9. Effect of jejunoileal bypass in the rat on the enteroinsular axis. Pederson RA; Buchan AM; Zahedi-Asl S; Chan CB; Brown JC Regul Pept; 1982 Dec; 5(1):53-63. PubMed ID: 6762622 [TBL] [Abstract][Full Text] [Related]
10. Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Sørensen TI; Lauritsen KB; Holst JJ; Stadil F; Andersen B Digestion; 1983; 26(3):137-45. PubMed ID: 6343164 [TBL] [Abstract][Full Text] [Related]
11. Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man. Thomas FB; Shook DF; O'Dorisio TM; Cataland S; Mekhjian HS; Caldwell JH; Mazzaferri EL Gastroenterology; 1977 Jan; 72(1):49-54. PubMed ID: 830237 [TBL] [Abstract][Full Text] [Related]
12. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522 [TBL] [Abstract][Full Text] [Related]
13. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients. Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641 [TBL] [Abstract][Full Text] [Related]
14. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042 [TBL] [Abstract][Full Text] [Related]
15. Influence of gastric inhibitory polypeptide antiserum on glucose-induced insulin secretion in rats. Ebert R; Creutzfeldt W Endocrinology; 1982 Nov; 111(5):1601-6. PubMed ID: 6751797 [TBL] [Abstract][Full Text] [Related]
16. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405 [TBL] [Abstract][Full Text] [Related]
17. The effect of oral galactose on GIP and insulin secretion in man. Morgan LM; Wright JW; Marks V Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694 [TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man. Salera M; Pironi L; Giacomoni P; Venturi S; Capelli M; Miglioli M; Barbara L Digestion; 1982; 24(2):126-32. PubMed ID: 6127273 [TBL] [Abstract][Full Text] [Related]
19. Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy. Lauritsen KB; Moesgaard F; Nielsen ML; Jensen SL Scand J Gastroenterol; 1982 Jun; 17(4):507-11. PubMed ID: 6753107 [TBL] [Abstract][Full Text] [Related]
20. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]